Related Experiment Videos
[Study of hemoglobin structure by a turbidimetric method]
Biofizika
|November 1, 1986
Summary
Phenylmercuryacetate binds stoichiometrically with human oxyhemoglobin (Hb) at low temperatures, preventing coagulation. Higher temperatures drastically reduce the reagent needed for Hb coagulation, suggesting specific binding sites are involved.
Area of Science:
- Biochemistry
- Protein Chemistry
Context:
- Human oxyhemoglobin (Hb) is crucial for oxygen transport.
- Understanding protein coagulation mechanisms is vital in biochemistry.
- Phenylmercuryacetate (PMA) is a known heavy metal compound.
Purpose:
- To determine the stoichiometric binding of phenylmercuryacetate with human oxyhemoglobin.
- To investigate the effect of temperature on oxyhemoglobin coagulation kinetics.
- To propose a model for oxyhemoglobin coagulation based on reagent binding.
Summary:
- The study measured the initial coagulation velocity of human oxyhemoglobin using a turbidimetric method in the presence of phenylmercuryacetate (PMA) at pH 7.2.
- At 15-30°C, 30-34 moles of PMA stoichiometrically bind per hemoglobin tetramer without causing coagulation.
- Increasing temperature from 30°C to 42.5°C significantly reduces the PMA amount required for protein coagulation, indicating a temperature-dependent interaction.
Impact:
- This research provides insights into the interaction between heavy metal compounds and hemoglobin.
- The proposed model suggests that oxyhemoglobin coagulation is initiated by PMA binding to specific protein sites.
- Findings contribute to understanding protein stability and denaturation processes.